Welcome to our dedicated page for ENDEXX news (Ticker: EDXC), a resource for investors and traders seeking the latest updates and insights on ENDEXX stock.
Endexx Corporation (EDXC) is a pioneer in the plant-based wellness sector, offering high-quality m3cbd® hemp-based nutritional extracts rich in non-psychoactive phyto-cannabinoids and terpenoids. They also provide m3vape® starter kits and accessories to enhance the customer experience. Endexx is committed to formulating products that enhance bioavailability, affordability, and overall customer satisfaction. Their mission is to advance the understanding of cannabinoids through research and collaborations with medical professionals.
Recently, the company announced a strategic update on its auditing practices, opting to engage a new independent auditor, Victor Mokuolu, CPA PLLC, to align with their growth strategy and ensure transparency. This decision reflects Endexx's dedication to operational excellence and shareholder value.
Rhea-AI Summary
Endexx (OTC: EDXC) rebrands to HYLA and secures a $348,812.50 distribution agreement with a Houston distributor, signaling a significant step in market expansion. The deal is expected to drive substantial revenue growth through quarterly orders of proprietary wellness products. CEO Nick Mehdi anticipates multimillion-dollar revenues and enhanced market presence, highlighting a strategic shift towards innovation and environmental stewardship.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.86%
Tags
-
Rhea-AI Summary
Endexx (OTC: EDXC) announces strategic moves to leverage new opportunities in European markets post-cannabis legalization in Germany, positioning the company and its HYLA brand at the forefront of plant-based wellness.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.35%
Tags
-
Rhea-AI Summary
Endexx Corporation (EDXC) appoints Victor Mokuolu, CPA PLLC as new independent auditor, signaling commitment to transparency and growth. The decision to engage VMCPA was made after challenges with previous auditors, Turner, Stone & Company. The transition is detailed in a recent Form 8-K/A filing with the SEC, reflecting Endexx's dedication to upholding financial reporting standards and accountability. The move aligns with the company's strategic vision for operational efficiency, sustainable growth, and shareholder value creation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.11%
Tags
News
Rhea-AI Summary
Endexx Corporation (EDXC) announces a strategic update on auditing and financial reporting processes, parting ways with previous auditors Turner, Stone & Company, L.L.P. The decision aims to enhance alignment and efficiency, ensuring transparency and operational excellence. The company is in the process of selecting a new auditor to support its growth trajectory and commitment to stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Endexx Corporation (EDXC) announces significant recalibration of leadership dynamics and board composition, welcoming Claude Zdanow as the second board member and entrusting him with the role of Investor Communications Lead. The company's recent strategic maneuvers, including distribution agreements and market entries, reflect its commitment to global expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.23%
Tags
-
Rhea-AI Summary
Endexx Corporation (EDXC): HYLA Targets 11 Key European Markets With TPD
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.48%
Tags
Rhea-AI Summary
Endexx Corporation announces progress update for its HYLA division, exceeding first year expectations. Sales of HYLA products reached five million in the first 14 months since launch. Distribution expanded to 11 international countries with secured government approvals. Re-order rates are accelerating, and product placement has been achieved in over 5,000 international locations. Endexx restructured convertible debt to fixed debt and reduced operating costs, driving the company to gross profitability. Anticipated annual growth for HYLA's products is projected to be 250-500% for the next 3-5 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
-
Rhea-AI Summary
Endexx Corporation announces progress update for 2023, highlighting accelerated revenue and international distribution since acquiring HYLA. Sales of HYLA products exceeded $5 million in the first 14 months since launch, with distribution in 11 international countries. Re-order rates are accelerating, and product placement has reached over 5,000 international locations. Endexx has restructured convertible debt to fixed debt and reduced operating costs, driving the company towards gross profitability. Anticipated annual growth for HYLA's products is 250-500% for the next 3-5 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
-
Rhea-AI Summary
Endexx Corporation announces strategic partnership with XVI Ventures to lead HYLA's marketing efforts in Italy
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
Rhea-AI Summary
$400,000 Reorder Highlights HYLA’s Accelerating Product Demand
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.86%
Tags
FAQ
What is the current stock price of ENDEXX (EDXC)?
The current stock price of ENDEXX (EDXC) is $0.00975 as of December 20, 2024.
What is the market cap of ENDEXX (EDXC)?
The market cap of ENDEXX (EDXC) is approximately 4.9M.
What products does Endexx Corporation offer?
Endexx Corporation provides high-quality m3cbd® hemp-based nutritional extracts rich in non-psychoactive phyto-cannabinoids and terpenoids. They also offer m3vape® starter kits and accessories.
What is Endexx's mission?
Endexx Corporation aims to advance the understanding of cannabinoids through research and collaborations with medical professionals. They strive to offer products that enhance bioavailability, affordability, and customer satisfaction.
What recent strategic update did Endexx announce?
Endexx Corporation recently engaged Victor Mokuolu, CPA PLLC, as their new independent auditor to align with their growth strategy and ensure transparency in their auditing practices.
How does Endexx Corporation demonstrate its commitment to operational excellence?
Endexx Corporation demonstrates its commitment to operational excellence by making strategic decisions that enhance transparency, align with their growth strategy, and uphold the highest standards of accuracy in their financial reporting.
What sets Endexx Corporation apart in the plant-based wellness sector?
Endexx Corporation sets itself apart in the plant-based wellness sector by offering high-quality, innovative products that focus on enhancing bioavailability, affordability, and customer satisfaction. Their dedication to research and collaboration with medical professionals further distinguishes them in the industry.
ENDEXX CORP
OTC:EDXC
EDXC Rankings
EDXC Stock Data
4.94M
474.28M
6.34%
Drug Manufacturers - Specialty & Generic
Healthcare
United States of America
Cave Creek